Showing results (91-100 of 159) with videos related to

Sort By:
Pageof 16
Human Molecular Genetics|October 22, 2004
Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839)Soji Kakiuchi, Yataro Daigo, Nobuhisa Ishikawa, et al.
Molecular & Cellular Proteomics : MCP|September 3, 2010
Development of serum glycoproteomic profiling technique; simultaneous identification of glycosylation sites and site-specific quantification of glycan structure changesKoji Ueda, Sachiko Takami, Naomi Saichi, et al.
Cancer Science|June 6, 2009
Activation of an estrogen/estrogen receptor signaling by BIG3 through its inhibitory effect on nuclear transport of PHB2/REA in breast cancerJung-Won Kim, Miki Akiyama, Jae-Hyun Park, et al.
Cancer Letters|April 23, 2013
Deregulation of the histone demethylase JMJD2A is involved in human carcinogenesis through regulation of the G(1)/S transitionMasaharu Kogure, Masashi Takawa, Hyun-Soo Cho, et al.
Anticancer Research|February 2, 2024
Discrepancies Between Morphological and Immunohistochemical Classifications Are Associated With Prognoses and Subtypes of Lung CancerKosuke Natsume, Juanjuan Ye, Yuri Mukai, et al.
Cancer Science|July 26, 2006
Characterization of SEZ6L2 cell-surface protein as a novel prognostic marker for lung cancerNobuhisa Ishikawa, Yataro Daigo, Atsushi Takano, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 25, 2012
Reevaluation of a lectin antibody ELISA kit for measuring fucosylated haptoglobin in various conditionsYoshihiro Kamada, Noriaki Kinoshita, Yoko Tsuchiya, et al.
Cancer Research|October 19, 2005
Increases of amphiregulin and transforming growth factor-alpha in serum as predictors of poor response to gefitinib among patients with advanced non-small cell lung cancersNobuhisa Ishikawa, Yataro Daigo, Atsushi Takano, et al.
Immunological Medicine|November 26, 2019
Prognostic value of IL-34 in colorectal cancer patientsTakuto Kobayashi, Muhammad Baghdadi, Nanumi Han, et al.
Scientific Reports|January 12, 2018
High co-expression of IL-34 and M-CSF correlates with tumor progression and poor survival in lung cancersMuhammad Baghdadi, Hiraku Endo, Atsushi Takano, et al.
Pageof 16